284 related articles for article (PubMed ID: 28141919)
1. Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis.
Arnaud L; Nordin A; Lundholm H; Svenungsson E; Hellbacher E; Wikner J; Zickert A; Gunnarsson I
Arthritis Rheumatol; 2017 Jun; 69(6):1272-1279. PubMed ID: 28141919
[TBL] [Abstract][Full Text] [Related]
2. Profile of sex hormones in male patients with systemic lupus erythematosus.
Mok CC; Lau CS
Lupus; 2000; 9(4):252-7. PubMed ID: 10866095
[TBL] [Abstract][Full Text] [Related]
3. Ovarian function and disease activity in patients with systemic lupus erythematosus.
Shabanova SS; Ananieva LP; Alekberova ZS; Guzov II
Clin Exp Rheumatol; 2008; 26(3):436-41. PubMed ID: 18578965
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus: sex hormones in male patients.
Sequeira JF; Keser G; Greenstein B; Wheeler MJ; Duarte PC; Khamashta MA; Hughes GR
Lupus; 1993 Oct; 2(5):315-7. PubMed ID: 8305925
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Hu SC; Yen FL; Wang TN; Lin YC; Lin CL; Chen GS
J Am Acad Dermatol; 2016 Jul; 75(1):49-58. PubMed ID: 26946984
[TBL] [Abstract][Full Text] [Related]
6. Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.
Tamirou F; Husson SN; Gruson D; Debiève F; Lauwerys BR; Houssiau FA
Arthritis Rheumatol; 2017 Jun; 69(6):1267-1271. PubMed ID: 28235250
[TBL] [Abstract][Full Text] [Related]
7. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.
Manger K; Wildt L; Kalden JR; Manger B
Autoimmun Rev; 2006 Apr; 5(4):269-72. PubMed ID: 16697968
[TBL] [Abstract][Full Text] [Related]
8. [An analysis of the hormonal response during the performance of stress tests in patients with systemic lupus erythematosus and systemic scleroderma].
Dosin IuM; Apanasovich VG; Bolotina NG; Kurchenkova VI; Grigorchuk IP; Lazareva VI; Iagur VE
Ter Arkh; 1992; 64(5):75-7. PubMed ID: 1333648
[TBL] [Abstract][Full Text] [Related]
9. Assessment of ovarian reserve by serum anti-Müllerian hormone in patients with systemic lupus erythematosus: a meta-analysis.
Luo W; Mao P; Zhang L; Chen X; Yang Z
Ann Palliat Med; 2020 Mar; 9(2):207-215. PubMed ID: 32156138
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
11. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
Somers EC; Marder W; Christman GM; Ognenovski V; McCune WJ
Arthritis Rheum; 2005 Sep; 52(9):2761-7. PubMed ID: 16142702
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
Akawatcharangura P; Taechakraichana N; Osiri M
Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
[TBL] [Abstract][Full Text] [Related]
13. Androgenic status of males with systemic lupus erythematosus.
Stahl NI; Decker JL
Arthritis Rheum; 1978; 21(6):665-8. PubMed ID: 736997
[TBL] [Abstract][Full Text] [Related]
14. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus.
Köller MD; Templ E; Riedl M; Clodi M; Wagner O; Smolen JS; Luger A
Ann Rheum Dis; 2004 Dec; 63(12):1677-80. PubMed ID: 15082470
[TBL] [Abstract][Full Text] [Related]
15. Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.
Mok CC; Chan PT; To CH
Arthritis Rheum; 2013 Jan; 65(1):206-10. PubMed ID: 23044647
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid effects on myocardial performance in patients with systemic sclerosis.
Antoniades L; Sfikakis PP; Mavrikakis M
Clin Exp Rheumatol; 2001; 19(4):431-7. PubMed ID: 11491499
[TBL] [Abstract][Full Text] [Related]
17. Ovarian failure and flares of systemic lupus erythematosus.
Mok CC; Wong RW; Lau CS
Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide: similarities and differences in the treatment of SSc and SLE.
Bruni C; Shirai Y; Kuwana M; Matucci-Cerinic M
Lupus; 2019 Apr; 28(5):571-574. PubMed ID: 30961417
[No Abstract] [Full Text] [Related]
19. The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus.
Steen SO; Iversen LV; Carlsen AL; Burton M; Nielsen CT; Jacobsen S; Heegaard NH
J Rheumatol; 2015 Feb; 42(2):214-21. PubMed ID: 25399392
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus.
Vilarinho ST; Costallat LT
J Rheumatol; 1998 Jun; 25(6):1097-103. PubMed ID: 9632070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
